All In MedTech

Device Trial Radar · NCT01940185

A Post-Approval Study of the LINX® Reflux Management System

Last checked: Nov 20, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

200

Actual

Start

Jun 30, 2012

Primary completion

Jun 30, 2023

Study completion Jun 30, 2023

Sponsor

Lead sponsor
Torax Medical IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Sep 12, 2013

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

  • LINX deviceDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction of total GERD-HRQL scoreTime frame: 6 months, 12 months, and annually to 60 months

1 more outcomes with a free account

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Keck Medical Center of Univeristy of Southern California

    Los Angeles, California

18 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.